IART INTEGRA LIFESCIENCES HOLDIN...

Nasdaq integralife.com


$ 11.40 $ 0.02 (0.18 %)    

Tuesday, 04-Nov-2025 12:22:54 EST
QQQ $ 622.08 $ -1.17 (-0.19 %)
DIA $ 471.02 $ 0.66 (0.14 %)
SPY $ 676.68 $ 0.56 (0.08 %)
TLT $ 89.94 $ 0.14 (0.16 %)
GLD $ 364.51 $ 0.93 (0.26 %)
$ 11.49
$ 11.58
$ 11.39 x 5
$ 11.44 x 4
$ 11.35 - $ 11.58
$ 11.05 - $ 27.13
1,683,525
na
894.98M
$ 1.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 07-31-2025 06-30-2025 10-Q
3 05-05-2025 03-31-2025 10-Q
4 02-25-2025 12-31-2024 10-K
5 11-04-2024 09-30-2024 10-Q
6 07-29-2024 06-30-2024 10-Q
7 05-06-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 10-25-2023 09-30-2023 10-Q
10 07-27-2023 06-30-2023 10-Q
11 04-26-2023 03-31-2023 10-Q
12 02-22-2023 12-31-2022 10-K
13 10-26-2022 09-30-2022 10-Q
14 07-27-2022 06-30-2022 10-Q
15 04-27-2022 03-31-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 07-29-2021 06-30-2021 10-Q
19 04-29-2021 03-31-2021 10-Q
20 02-23-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-21-2020 12-31-2019 10-K
25 10-25-2019 09-30-2019 10-Q
26 07-25-2019 06-30-2019 10-Q
27 04-29-2019 03-31-2019 10-Q
28 02-26-2019 12-31-2018 10-K
29 11-01-2018 09-30-2018 10-Q
30 07-26-2018 06-30-2018 10-Q
31 04-26-2018 03-31-2018 10-Q
32 03-01-2018 12-31-2017 10-K
33 10-26-2017 09-30-2017 10-Q
34 07-26-2017 06-30-2017 10-Q
35 04-26-2017 03-31-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 10-28-2016 09-30-2016 10-Q
38 07-28-2016 06-30-2016 10-Q
39 04-27-2016 03-31-2016 10-Q
40 02-26-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 truist-securities-reiterates-hold-on-integra-lifesciences-lowers-price-target-to-13

Truist Securities analyst Ravi Misra reiterates Integra Lifesciences (NASDAQ:IART) with a Hold and lowers the price target f...

 citigroup-maintains-sell-on-integra-lifesciences-lowers-price-target-to-11

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and lowers the price target from $...

 jp-morgan-maintains-underweight-on-integra-lifesciences-raises-price-target-to-13

JP Morgan analyst Robbie Marcus maintains Integra Lifesciences (NASDAQ:IART) with a Underweight and raises the price target ...

 integra-lifesciences-sees-q4-adj-eps-079-084-vs-092-est-sees-sales-420000m-440000m-vs-456197m-est

Integra Lifesciences (NASDAQ:IART) is looking for Q4 Adj EPS of $0.79-$0.84 vs $0.92 analyst estimate. sees sales of $420.000 m...

 integra-lifesciences-narrows-fy2025-adj-eps-guidance-from-219-229-to-219-224-vs-221-est-lowers-fy2025-sales-guidance-from-1655b-1680b-to-1620b-1640b-vs-1669b-est

Integra Lifesciences (NASDAQ:IART) narrows FY2025 Adj EPS guidance from $2.19-$2.29 to $2.19-$2.24 vs $2.21 analyst estimate. L...

 integra-lifesciences-q3-adj-eps-054-beats-043-estimate-sales-402062m-miss-414256m-estimate

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of ...

 truist-securities-maintains-hold-on-integra-lifesciences-raises-price-target-to-15

Truist Securities analyst Richard Newitter maintains Integra Lifesciences (NASDAQ:IART) with a Hold and raises the price tar...

 integra-lifesciences-to-showcase-new-neurosurgical-innovations-at-cns-2025-in-los-angeles-october-11-through-15-2025

- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, is pleased to announce ...

 integra-lifesciences-affirms-fy2025-adj-eps-guidance-of-219-229-vs-224-est-narrows-fy2025-sales-guidance-from-1650b-1715b-to-1655b-1680b-vs-1667b-est

Integra Lifesciences (NASDAQ:IART) affirms FY2025 Adj EPS guidance from $2.19-$2.29 to $2.19-$2.29 vs $2.24 analyst estimate. N...

 integra-lifesciences-sees-q3-adj-eps-040-045-vs-058-est-sees-sales-410000m-420000m-vs-418831m-est

Integra Lifesciences (NASDAQ:IART) is looking for Q3 Adj EPS of $0.40-$0.45 vs $0.58 analyst estimate. sees sales of $410.000 m...

 integra-lifesciences-q2-adj-eps-045-beats-043-estimate-sales-415605m-beat-395067m-estimate

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of ...

 fda-announces-applicator-recall-integra-lifesciences-removes-micromyst-applicators-due-to-potential-sterility-concerns

https://www.fda.gov/medical-devices/medical-device-recalls/applicator-recall-integra-lifesciences-removes-micromyst-applicators...

 cranial-drill-recall-integra-lifesciences-recalls-codman-disposable-perforators-due-to-risk-of-device-disassembly---fda

https://www.fda.gov/medical-devices/medical-device-recalls/cranial-drill-recall-integra-lifesciences-recalls-codman-disposable-...

 jmp-securities-maintains-market-outperform-on-integra-lifesciences-lowers-price-target-to-25

JMP Securities analyst David Turkaly maintains Integra Lifesciences (NASDAQ:IART) with a Market Outperform and lowers the pr...

 jp-morgan-maintains-underweight-on-integra-lifesciences-lowers-price-target-to-12

JP Morgan analyst Robbie Marcus maintains Integra Lifesciences (NASDAQ:IART) with a Underweight and lowers the price target ...

 wells-fargo-maintains-equal-weight-on-integra-lifesciences-lowers-price-target-to-13

Wells Fargo analyst Vik Chopra maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Weight and lowers the price target ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION